Skip to main content

Editorial reviews. Affiliate fees from some providers don't affect rankings. Disclosure

No advertiser influenceAffiliate fees disclosedReviewed by board-certified clinicians
Skip to article body

guide

FSH testing in perimenopause: when it helps and when it misleads

FSH testing is widely ordered for perimenopause but the single value fluctuates so much it usually misleads. Knowing the test's limits prevents wasted appointments.

Written by Sarah Editor, MA Journalism, Certified Menopause CoachMedically reviewed by Jane Smith, MD, MD, NAMS-certifiedUpdated Clinically reviewed
Why you can trust this article

Editorial independence. Our reviewers and writers operate independently from any telehealth partner. Recommendations are based on published clinical evidence and direct evaluation of provider services.

Corrections policy. Errors are flagged at the top of the page and logged in our public corrections register.

Affiliate disclosure. Some links may earn us a commission at no extra cost to you. This never influences what we recommend. See our full affiliate disclosure.

Follicle-stimulating hormone (FSH) is one of the most-ordered tests in women asking "am I in perimenopause?" — and one of the most overinterpreted. Levels swing widely across the transition, and a single result rarely answers the question reliably.

What FSH measures

FSH is produced by the pituitary and signals the ovaries to mature follicles. As ovarian reserve declines, less estrogen is produced, the pituitary loses negative feedback, and FSH rises. In the reproductive years, FSH peaks briefly at ovulation and otherwise sits below 10 mIU/mL. In postmenopause, FSH stabilizes above 25–30 mIU/mL, sometimes reaching 70+ mIU/mL.

The fluctuation problem

During perimenopause, FSH does not rise smoothly. It bounces — high one month, near-premenopausal the next, driven by intermittent ovarian function. A 2007 SWAN study sub-analysis found that single FSH measurements correctly classified menopausal status in only about 60% of late-transition women. This is why the STRAW+10 framework — the global staging consensus — explicitly demotes FSH from a primary staging tool to a secondary check.

When the test is useful

FSH adds value in specific situations. After a hysterectomy with ovaries intact, there's no menstrual history to stage from — FSH plus symptom profile fills the gap. In suspected premature ovarian insufficiency (POI) under age 40, FSH > 25 mIU/mL on two readings 4–6 weeks apart is part of the diagnostic criteria. For women considering fertility planning, FSH adds context to anti-müllerian hormone (AMH) and antral follicle counts.

When the test misleads

FSH is unreliable in any of the following: while on hormonal contraception (estradiol suppresses pituitary FSH artificially), within 6 weeks of stopping oral contraceptives, with anovulatory cycles from PCOS or hypothalamic causes, or as a single value across the noisy mid-transition. If a clinician orders FSH for any of these, ask whether the result will actually change management.

What to test instead

For perimenopausal symptoms, the most useful workup is usually: TSH (rule out thyroid mimicking peri), CBC and ferritin (rule out anemia and iron deficiency, especially with heavy bleeding), vitamin D and B12 (if cognitive or mood symptoms predominate), and fasting glucose with A1c (rule out insulin resistance for weight changes). The diagnosis of perimenopause is primarily clinical — symptoms plus cycle pattern — not laboratory-driven.

Informational only — your clinician decides which labs make sense for your situation.

Sources & credits

Medically reviewed by

Jane Smith, MD, MD, NAMS-certified

Board-certified OB/GYN and NAMS-certified menopause practitioner with 15 years of clinical experience in midlife women's health.

See full credentials →